Efficacy of Trastuzumab Deruxtecan in HER2-Expressing Solid Tumors by Enrollment HER2 IHC Status: Post Hoc Analysis of DESTINY-PanTumor02

  1. Oaknin, A.
  2. Lee, J.-Y.
  3. Makker, V.
  4. Oh, D.-Y.
  5. Banerjee, S.
  6. González-Martín, A.
  7. Jung, K.H.
  8. Ługowska, I.
  9. Manso, L.
  10. Manzano, A.
  11. Melichar, B.
  12. Siena, S.
  13. Stroyakovskiy, D.
  14. Fielding, A.
  15. Puvvada, S.
  16. Smith, A.
  17. Meric-Bernstam, F.
Aldizkaria:
Advances in Therapy

ISSN: 1865-8652,  0741-238X

Argitalpen urtea: 2024

Alea: 41

Zenbakia: 11

Orrialdeak: 4125-4139

Mota: Artikulua

DOI: 10.1007/S12325-024-02975-X GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus